Trump doesn’t have a clue about healthcare
In a press briefing Monday morning, President Donald Trump said, according to multiple news outlets, that, "Nobody knew that healthcare could be so complicated."
Reform healthcare payment while interest rates are low, says ex-HHS Secretary Leavitt
If and when rates rise again, the cost of debt service will be competing with healthcare and a couple other major components of the federal budget for ever scarcer dollars, Leavitt explained at HIMSS17 this week.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Grassley opens probe into Orphan Drug Act abuses
In a statement, Grassley said the inquiry is “based on reporting from Kaiser Health News” and strong consumer concern about high drug prices.
New home health rules focus on care coordination, patients’ rights
The new rules are set to go into effect in July, but they may be delayed as President Donald Trump’s administration reviews regulations that have been drafted or finalized but not yet implemented.
Conservatives getting antsy over ACA repeal
Sen. Mike Lee (R-Utah) one of the leading conservative voices in that chamber, said he will vigorously oppose efforts for Republicans to wait until they have a plan ready to replace the law before they repeal it.
Price made dozens of health stock trades even as committee was investigated
Craig Holman, government affairs lobbyist with Public Citizen, described Price’s volume of stock trades during the SEC inquiry as “brazen,” given the congressman’s access to nonpublic information affecting the companies’ fortunes.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Repeal and replace turns to ‘fixing’ Obamacare as AARP rattles sabers
There's long been an unwritten rule in Washington: Don't piss off seniors, because they vote in higher percentages than younger demographics.
HHS nominee Price clears Senate committee with no Democrats present (updated)
Senate Finance Committee Chairman Sen. Orrin Hatch (R-Utah) suspended rules requiring a quorum for a vote, allowing Price to advance to the full Senate.
Rogue social media movement expands to HealthCare.gov ads
Actor/comedian Colton Dunn, of "Superstore" on NBC, has picked up the slack, posting a series of low-budget but effective videos as alternative ads for HealthCare.gov.
HHS scientists get in on ‘rogue’ social media
@AltHHS describes itself as "Unofficial and unaffiliated resistance account by concerned scientists for humanity."
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Price grilled over Medicare innovation, Medicaid block grants
Senate Finance Committee ranking member Ron Wyden (D-Oregon) was rather relentless in questioning Price.
At least 6 senators grilling HHS nominee Tom Price also hold healthcare stocks
At least six members of the two Senate committees tasked with questioning or confirming Tom Price for HHS secretary hold shares in healthcare companies — such as Merck, Medtronic and Gilead — according to a Kaiser Health News analysis.
Tom Price’s top backer told employees to give to PAC
The PAC was operated by Georgia-based MiMedx, whose CEO Parker H. “Pete” Petit is among the top individual contributors to Price. Federal election law prohibits corporations from coercing employees to contribute to PACs.
Australian biotech company offered sweetheart investment deal to Tom Price
Price told HHS ethics officials Thursday that if appointed to be HHS secretary, he will divest himself of the Australian stock as well as stock in about 40 other companies that could pose conflicts.
Consumer tech companies developing OTC hearing aids
Several recent developments are of note as consumer electronics companies, hearing aid manufacturers, audiologists, physicians, consumer advocates and regulators prepare for a surge of new hearing devices and changes in the hearing healthcare system.